3 September 2020 - Utrecht
Today Nutrileads announces a new financing round that will enable them to bring their first product to market. We are thrilled to be part of this new financing round of Nutrileads, and welcome the entry of new investors Icos Capital and Groeie Grutten Impact Fund, who are experienced in the fields of health and nutrition.
Nutrileads identifies and develops natural food ingredients with (yet to be) proven health benefits. The proof for such a benefit (a "health claim") is obtained by demonstrating the benefits in controlled clinical trials. Subsequently the ingredient and products carrying the ingredient will require approval by the authorities to use such claims commercially towards health professionals and consumers.
As an investor in the healthcare space, in particular in the development of novel therapeutics, Thuja is very familiar with proving health claims through clinical trials and the associated regulatory rigor that is required. Hence, we are also open to food-based products pursuing health claims, as long as there is a solid scientific basis underpinning the proposition and a team that understands this business really well. Nutrileads ticks all boxes in this respect.
We firmly believe that selected food ingredients with proven health benefits can contribute to the health of consumers and prevent disease. In those people with health issues such natural health ingredients are important to promote speedy recovery. Hence, Nutrileads fits well to our ambition to promote healthcare.
Please find the full press release here.